Summary of clinical features observed in individuals with PITX2-related ARS or FOXC1-related ARS in this cohort
Affected system* | PITX2 | FOXC1 | ||||||||
All N=59 | Deletion N=10 | PTC N=34 | Missense N=15 | All N=69 | Deletion N=22 | PTC N=27 | Missense N=20 | |||
Eye | Any anterior segment phenotype (%) | 100 | 100 | 100 | 100 | 91 | 100 | 85 | 90 | |
Anterior segment (%) | Typical ARS anomalies† | 93 | 100 | 88 | 100 | 72 | 73 | 77 | 65 | |
Corneal opacity† | 15 | 20 | 15 | 13 | 24 | 23 | 19 | 30 | ||
Aniridia† | 8 | 10 | 6 | 13 | 13 | 23 | 20 | |||
Primary CG | 0 | 0 | 0 | 0 | 3 | 5 | 4 | 0 | ||
Glaucoma details (%) | Any glaucoma onset (years) | 72 | 57 | 6 | 83 | 66 | 59 | 65 | 73 | |
dx <2 | 17 | 50 | 11 | 10 | 66 | 70 | 65 | 64 | ||
dx 2–10 | 30 | 25 | 22 | 40 | 21 | 10 | 18 | 36 | ||
dx 11–20 | 17 | 25 | 11 | 20 | 8 | 0 | 18 | 0 | ||
dx 21–60 | 26 | 0 | 56 | 10 | 5 | 20 | 0 | 0 | ||
dx age unknown | 9 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | ||
Treatment: drops only | 30 | 25 | 22 | 43 | 21 | 20 | 21 | 20 | ||
Treatment: surgical | 70 | 75 | 78 | 57 | 79 | 80 | 79 | 80 | ||
Dysmorphic facial features (%) | 93 | 100 | 87 | 100 | 78 | 71 | 89 | 73 | ||
Syndromic AAnomalies | Additional systemic anomalies (%) | 100 | 100 | 100 | 100 | 69 | 79 | 70 | 58 | |
Dental | Any dental anomaly | 91 | 100 | 86 | 92 | 42 | 67 | 43 | 14 | |
Microdontia/hypodontia | 91 | 100 | 86 | 92 | 0 | 0 | 0 | 0 | ||
Enamel hypoplasia/caries | 0 | 0 | 0 | 0 | 30 | 47 | 38 | 0 | ||
Other | 7 | 20 | 5 | 0 | 20 | 33 | 14 | 14 | ||
Umbilical | Any umbilical anomaly | 94 | 100 | 90 | 100 | 11 | 11 | 11 | 11 | |
RU | 42 | 56 | 42 | 42 | 9 | 11 | 11 | 5 | ||
UH | 33 | 11 | 39 | 33 | 0 | 0 | 0 | 0 | ||
OA | 15 | 33 | 10 | 17 | 0 | 0 | 0 | 0 | ||
Other/unspecified | 2 | 0 | 0 | 8 | 2 | 0 | 0 | 5 | ||
GI | Any GI defect | 42 | 60 | 41 | 33 | 22 | 26 | 22 | 16 | |
Meckel’s diverticulum | 26 | 30 | 25 | 27 | 0 | 0 | 0 | 0 | ||
Anal anomaly | 5 | 0 | 9 | 0 | 2 | 5 | 0 | 0 | ||
Constipation/IBS | 7 | 20 | 6 | 0 | 6 | 16 | 0 | 5 | ||
Feeding d/o | 2 | 10 | 0 | 0 | 14 | 11 | 19 | 11 | ||
Other features | Congenital heart defect | 7 | 20 | 6 | 0 | 32 | 32 | 22 | 47 | |
Hearing loss | 2 | 0 | 3 | 0 | 32 | 58 | 30 | 11 | ||
Hypospadias | 7 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | ||
Kidney anomalies | 4 | 0 | 6 | 0 | 8 | 16 | 4 | 5 | ||
Poor growth/FTT | 12 | 10 | 9 | 20 | 17 | 16 | 19 | 16 | ||
Hypotonia/early delays | 7 | 10 | 6 | 7 | 20 | 16 | 22 | 21 | ||
CI | 11 | 30 | 6 | 7 | 9 | 16 | 7 | 5 | ||
Abnormal brain imaging | NED | NED | NED | NED | 90 | 100 | 80 | 100 | ||
Any skeletal/joint anomalies | 9 | 10 | 13 | 0 | 25 | 32 | 19 | 26 | ||
Hip anomalies | 0 | 0 | 0 | 0 | 12 | 11 | 9 | 17 |
*information is included based on availability of relevant clinical data: structural eye anomalies (n=59, PITX2, and n=68, FOXC1); glaucoma, n=32 and 58; dysmorphic facial features, n=37 and 42; systemic anomalies, n=57 and 65; dental anomalies, n=44 and 50; umbilical anomalies, n=52 and 65; hypospadias, n=28 and 24.
†Includes patients with multiple ocular diagnoses; bolded features differ significantly between genes (p<0.05).
ARS, Axenfeld-Rieger syndrome; CG, congenital glaucoma; CI, cognitive impairment; d/o, disorder; dx, diagnosis; FTT, failure to thrive; GI, gastrointestinal; IBS, irritable bowel syndrome; NED, not enough data; OA, omphalocele; PTC, premature termination codon; RU, redundant umbilical skin; UH, umbilical hernia.